Safety, Pharmacokinetics, and Antiviral Activity of HGS004, a Novel Fully Human IgG4 Monoclonal Antibody against CCR5, in HIV‐1–Infected Patients

200872 citationsJournal Articlebronze Open Access

Authors

HGS004 is safe and well tolerated and demonstrates meaningful antiviral activity when administered to patients infected with CCR5-tropic HIV-1.

Good health and well-being

Published in: The Journal of Infectious Diseases

Volume 197, Issue 5, pp. 721-727

Field-Weighted Citation Impact: 4.29